Tuberculosis treatment is expensive for patients in developing countriesBMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7101.187a (Published 19 July 1997) Cite this as: BMJ 1997;315:187
- Elizabeth Bevan, Medical officer in chargea
- a PCEA Tumutumu Hospital, Private Bag, Karatina, Kenya
Editor—I was disappointed to read of the attitude of the World Health Organisation and others to the use of directly observed treatment short course (DOTS) for tuberculosis.1 Such treatment is described as a cheap and effective public health breakthrough. The failure of the method is blamed on doctors explicitly by Sir John Crofton and implicitly by the director of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial